Study Reveals Cervical Cancer Screening Prevented 5,500 Cases in Ireland

New research indicates that Ireland’s cervical cancer screening programme has successfully prevented over 5,500 cases of the disease. This significant finding was published by a team of researchers from Trinity College Dublin (TCD) in the European Journal of Public Health this month. The study highlights the effectiveness of the CervicalCheck programme, which has been operational since 2008.

According to the research, the screening initiative has effectively thwarted cancers that would have otherwise developed during the lifetimes of women who participated in the programme. A spokesperson from TCD stated, “The outcomes figured by the team give solid support for the clear efficacy of cervical cancer screening in Ireland and beyond.”

The study underscores a crucial aspect of public health interventions: when they succeed, their benefits often go unnoticed. The spokesperson elaborated, “With cervical screening and HPV vaccination, we do not see the cancers that are prevented.” By employing mathematical modelling, researchers can estimate the impact of screening, even for events that never occurred.

David Robert Grimes, co-lead author of the study and Assistant Professor in Biostatistics at TCD’s School of Medicine, explained the methodology behind the findings. He noted, “We can’t measure things that did not happen, but we can apply mathematical modelling to see what would likely have transpired if screening did not exist.”

This approach allows researchers to assess the long-term benefits of screening for women with cervical abnormalities. Grimes added, “To answer the question of how many lifetime cancers screening prevents, we have to ask a counterfactual question: if there was no screening, how would things have turned out for women with cervical abnormalities?”

The major conclusion drawn from the study is that cervical cancer screening in Ireland prevented over 5,500 lifetime cervical cancers between 2008 and 2022. The research also found that while cervical cancer rates were on the rise in Ireland from 1994, they now appear to be declining, even as the population continues to grow.

Grimes emphasized the significance of public health programmes, stating, “Public health interventions like screening and vaccination are too often victims of their own success, because when they work their victories are largely invisible.” He further noted that this analysis sheds light on the effectiveness of cervical screening, reinforcing the importance of the national programme in Ireland.

As the country continues to combat cervical cancer, this research serves as a powerful testament to the value of preventive healthcare initiatives. The findings not only affirm the success of the CervicalCheck programme but also highlight the need for ongoing support and awareness around cervical cancer prevention.